Rapid Recapitulation of Nonalcoholic Steatohepatitis upon Loss of Host Cell Factor 1 Function in Mouse Hepatocytes

REFERENCES

• Hardy T, Oakley F, Anstee QM, Day CP. 2016. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol 11:451–496. https://doi.org/10.1146/annurev-pathol-012615-044224.
   PubMed Web of Science ®Google Scholar
• Machado MV, Diehl AM. 2016. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150:1769–1777. https://doi.org/10.1053/j.gastro.2016.02.066.
   PubMed Web of Science ®Google Scholar
• Singh SP, Misra B, Kar SK, Panigrahi MK, Misra D, Bhuyan P, Pattnaik K, Meher C, Agrawal O, Rout N, Swain M. 2015. Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: is it different? Clin Res Hepatol Gastroenterol 39:482–488. https://doi.org/10.1016/j.clinre.2014.08.014.
   PubMed Web of Science ®Google Scholar
• Than NN, Newsome PN. 2015. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 239:192–202. https://doi.org/10.1016/j.atherosclerosis.2015.01.001.
   PubMed Web of Science ®Google Scholar
• Williams R, Taylor-Robinson SD. 2016. Clinical dilemmas in non-alcoholic fatty liver disease. John Wiley and Sons, Ltd, Chichester, UK.
   Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419. https://doi.org/10.1016/S0016-5085(99)70506-8.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M, Pagano G. 2011. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43:617–649. https://doi.org/10.3109/07853890.2010.518623.
   PubMed Web of Science ®Google Scholar
• Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM. 2009. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7:234–238. https://doi.org/10.1016/j.cgh.2008.11.005.
   PubMed Web of Science ®Google Scholar
• Berson A, De Beco V, Letteron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D. 1998. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764–774. https://doi.org/10.1016/S0016-5085(98)70590-6.
   PubMed Web of Science ®Google Scholar
• Koteish A, Mae Diehl A. 2002. Animal models of steatohepatitis. Best Pract Res Clin Gastroenterol 16:679–690. https://doi.org/10.1053/bega.2002.0332.
   PubMed Web of Science ®Google Scholar
• Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. 2011. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141:1249–1253. https://doi.org/10.1053/j.gastro.2011.06.061.
   PubMed Web of Science ®Google Scholar
• Kanuri G, Bergheim I. 2013. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int J Mol Sci 14:11963–11980. https://doi.org/10.3390/ijms140611963.
   PubMed Web of Science ®Google Scholar
• Kohli R, Feldstein AE. 2011. NASH animal models: are we there yet? J Hepatol 55:941–943. https://doi.org/10.1016/j.jhep.2011.04.010.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Soejima Y, Fukusato T. 2012. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 18:2300–2308. https://doi.org/10.3748/wjg.v18.i19.2300.
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S, Fiel MI, Goossens N, Chou HI, Hoshida Y, Friedman SL. 2018. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol 69:385–395. https://doi.org/10.1016/j.jhep.2018.03.011.
   PubMed Web of Science ®Google Scholar
• Dejosez M, Levine SS, Frampton GM, Whyte WA, Stratton SA, Barton MC, Gunaratne PH, Young RA, Zwaka TP. 2010. Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. Genes Dev 24:1479–1484. https://doi.org/10.1101/gad.1935210.
   PubMed Web of Science ®Google Scholar
• Michaud J, Praz V, James Faresse N, Jnbaptiste CK, Tyagi S, Schutz F, Herr W. 2013. HCFC1 is a common component of active human CpG-island promoters and coincides with ZNF143, THAP11, YY1, and GABP transcription factor occupancy. Genome Res 23:907–916. https://doi.org/10.1101/gr.150078.112.
   PubMed Web of Science ®Google Scholar
• Zargar Z, Tyagi S. 2012. Role of host cell factor-1 in cell cycle regulation. Transcription 3:187–192. https://doi.org/10.4161/trns.20711.
   PubMedGoogle Scholar
• Goto H, Motomura S, Wilson AC, Freiman RN, Nakabeppu Y, Fukushima K, Fujishima M, Herr W, Nishimoto T. 1997. A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function. Genes Dev 11:726–737. https://doi.org/10.1101/gad.11.6.726.
   PubMed Web of Science ®Google Scholar
• Julien E, Herr W. 2003. Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1. EMBO J 22:2360–2369. https://doi.org/10.1093/emboj/cdg242.
   PubMed Web of Science ®Google Scholar
• Minocha S, Bessonnard S, Sung TL, Moret C, Constam DB, Herr W. 2016. Epiblast-specific loss of HCF-1 leads to failure in anterior-posterior axis specification. Dev Biol 418:75–88. https://doi.org/10.1016/j.ydbio.2016.08.008.
   PubMed Web of Science ®Google Scholar
• Minocha S, Sung TL, Villeneuve D, Lammers F, Herr W. 2016. Compensatory embryonic response to allele-specific inactivation of the murine X-linked gene Hcfc1. Dev Biol 412:1–17. https://doi.org/10.1016/j.ydbio.2016.02.019.
   PubMed Web of Science ®Google Scholar
• Reilly PT, Herr W. 2002. Spontaneous reversion of tsBN67 cell proliferation and cytokinesis defects in the absence of HCF-1 function. Exp Cell Res 277:119–130. https://doi.org/10.1006/excr.2002.5551.
   PubMed Web of Science ®Google Scholar
• Huang L, Jolly LA, Willis-Owen S, Gardner A, Kumar R, Douglas E, Shoubridge C, Wieczorek D, Tzschach A, Cohen M, Hackett A, Field M, Froyen G, Hu H, Haas SA, Ropers HH, Kalscheuer VM, Corbett MA, Gecz J. 2012. A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disability. Am J Hum Genet 91:694–702. https://doi.org/10.1016/j.ajhg.2012.08.011.
   PubMed Web of Science ®Google Scholar
• Jolly LA, Nguyen LS, Domingo D, Sun Y, Barry S, Hancarova M, Plevova P, Vlckova M, Havlovicova M, Kalscheuer VM, Graziano C, Pippucci T, Bonora E, Sedlacek Z, Gecz J. 2015. HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain. Hum Mol Genet 24:3335–3347. https://doi.org/10.1093/hmg/ddv083.
   PubMed Web of Science ®Google Scholar
• Koufaris C, Alexandrou A, Tanteles GA, Anastasiadou V, Sismani C. 2016. A novel HCFC1 variant in male siblings with intellectual disability and microcephaly in the absence of cobalamin disorder. Biomed Rep 4:215–218. https://doi.org/10.3892/br.2015.559.
   PubMedGoogle Scholar
• Yu HC, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, Manoli I, Coughlin CR, II, Geiger EA, Schneck U, Watkins D, Suormala T, Van Hove JL, Fowler B, Baumgartner MR, Rosenblatt DS, Venditti CP, Shaikh TH. 2013. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. Am J Hum Genet 93:506–514. https://doi.org/10.1016/j.ajhg.2013.07.022.
   PubMed Web of Science ®Google Scholar
• Ruan HB, Han X, Li MD, Singh JP, Qian K, Azarhoush S, Zhao L, Bennett AM, Samuel VT, Wu J, Yates JR, III, Yang X. 2012. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability. Cell Metab 16:226–237. https://doi.org/10.1016/j.cmet.2012.07.006.
   PubMed Web of Science ®Google Scholar
• Wilson AC, Peterson MG, Herr W. 1995. The HCF repeat is an unusual proteolytic cleavage signal. Genes Dev 9:2445–2458.
   PubMed Web of Science ®Google Scholar
• Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M. 2011. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60:404–413. https://doi.org/10.1016/j.metabol.2010.03.006.
   PubMed Web of Science ®Google Scholar
• Sookoian S, Pirola CJ. 2014. NAFLD. Metabolic make-up of NASH: from fat and sugar to amino acids. Nat Rev Gastroenterol Hepatol 11:205–207. https://doi.org/10.1038/nrgastro.2014.25.
   PubMed Web of Science ®Google Scholar
• Krahenbuhl L, Lang C, Ludes S, Seiler C, Schafer M, Zimmermann A, Krahenbuhl S. 2003. Reduced hepatic glycogen stores in patients with liver cirrhosis. Liver Int 23:101–109. https://doi.org/10.1034/j.1600-0676.2003.00805.x.
   PubMed Web of Science ®Google Scholar
• Ahishali E, Demir K, Ahishali B, Akyuz F, Pinarbasi B, Poturoglu S, Ibrisim D, Gulluoglu M, Ozdil S, Besisik F, Kaymakoglu S, Boztas G, Cakaloglu Y, Mungan Z, Canberk Y, Okten A. 2010. Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? J Gastroenterol Hepatol 25:619–626. https://doi.org/10.1111/j.1440-1746.2009.06142.x.
   PubMed Web of Science ®Google Scholar
• Jayakumar S, Guillot S, Argo C, Redick J, Caldwell S. 2011. Ultrastructural findings in human nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 5:141–145. https://doi.org/10.1586/egh.11.9.
   PubMed Web of Science ®Google Scholar
• Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM. 2009. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression. Diabetes 58:1499–1508. https://doi.org/10.2337/db08-1571.
   PubMed Web of Science ®Google Scholar
• Finck BN, Kelly DP. 2006. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Investig 116:615–622. https://doi.org/10.1172/JCI27794.
   PubMed Web of Science ®Google Scholar
• Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP. 2005. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3:e101. https://doi.org/10.1371/journal.pbio.0030101.
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25–29. https://doi.org/10.1038/75556.
   PubMed Web of Science ®Google Scholar
• Supek F, Bosnjak M, Skunca N, Smuc T. 2011. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One 6:e21800. https://doi.org/10.1371/journal.pone.0021800.
   PubMed Web of Science ®Google Scholar
• Fausto N, Campbell JS, Riehle KJ. 2006. Liver regeneration. Hepatology 43:S45. https://doi.org/10.1002/hep.20969.
   PubMedGoogle Scholar
• Michalopoulos GK. 2007. Liver regeneration. J Cell Physiol 213:286–300. https://doi.org/10.1002/jcp.21172.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. 2017. Hepatostat: liver regeneration and normal liver tissue maintenance. Hepatology 65:1384–1392. https://doi.org/10.1002/hep.28988.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK, DeFrances MC. 1997. Liver regeneration. Science 276:60–66. https://doi.org/10.1126/science.276.5309.60.
   PubMed Web of Science ®Google Scholar
• Alison MR, Islam S, Lim S. 2009. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 217:282–298. https://doi.org/10.1002/path.2453.
   PubMed Web of Science ®Google Scholar
• Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA, Ye L, Kopp JL, Sander M, Carter H, Deisseroth K, Verma IM, Karin M. 2015. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 162:766–779. https://doi.org/10.1016/j.cell.2015.07.026.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. 2011. Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol 43:173–179. https://doi.org/10.1016/j.biocel.2009.09.014.
   PubMed Web of Science ®Google Scholar
• Taub R. 2004. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5:836–847. https://doi.org/10.1038/nrm1489.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhao L, Fish M, Logan CY, Nusse R. 2015. Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524:180–185. https://doi.org/10.1038/nature14863.
   PubMed Web of Science ®Google Scholar
• Hines IN, Kremer M, Isayama F, Perry AW, Milton RJ, Black AL, Byrd CL, Wheeler MD. 2007. Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology 46:229–241. https://doi.org/10.1002/hep.21674.
   PubMed Web of Science ®Google Scholar
• Kofman AV, Morgan G, Kirschenbaum A, Osbeck J, Hussain M, Swenson S, Theise ND. 2005. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 41:1252–1261. https://doi.org/10.1002/hep.20696.
   PubMed Web of Science ®Google Scholar
• Sanches SC, Ramalho LN, Augusto MJ, da Silva DM, Ramalho FS. 2015. Nonalcoholic steatohepatitis: a search for factual animal models. Biomed Res Int 2015:1. https://doi.org/10.1155/2015/574832.
   Web of Science ®Google Scholar
• Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M. 2004. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med 10:530–534. https://doi.org/10.1038/nm1044.
   PubMed Web of Science ®Google Scholar
• Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM. 2004. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119:121–135. https://doi.org/10.1016/j.cell.2004.09.013.
   PubMed Web of Science ®Google Scholar
• Schuler M, Dierich A, Chambon P, Metzger D. 2004. Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse. Genesis 39:167–172. https://doi.org/10.1002/gene.20039.
   PubMed Web of Science ®Google Scholar
• Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. 2000. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29:52–54. https://doi.org/10.2144/00291bm09.
   PubMed Web of Science ®Google Scholar